Search results
Results from the WOW.Com Content Network
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. [9] One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. [ 10 ] Two doses of vaccine are more effective than one. [ 10 ]
This vaccine is a 2 or 3 dose series, depending on the brand of the vaccine, that is given at 2 and 4 months in the 2 dose series and at 2,4 and 6 months in the 3 dose series. Studies show that this vaccine is 85-98% effective against severe rotavirus disease and is 74-87% effective against rotavirus disease of any severity in the first year ...
ACIP statements are official federal recommendations for the use of vaccines and immune globulins in the U.S., and are published by the CDC. ACIP reports directly to the CDC director, although its management and support services are provided by CDC's National Center for Immunization and Respiratory Diseases. [1]
NCIRD supports and supervises state and local agencies working on immunization activities and commercial contracting for vaccine supply and distribution. NCIRD supports a national framework for surveillance of diseases for which immunizing agents are increasingly becoming available from commercial pharmaceutical companies, and assists health departments in developing vaccine information ...
In 1995, Merck & Co. licensed the "Oka" strain of the varicella virus in the United States, and Maurice Hilleman's team at Merck invented a varicella vaccine in the same year. [42] [43] [44] The varicella vaccine is recommended in many countries. [12] Some countries require the varicella vaccination or an exemption before entering elementary ...
A Vaccine Information Statement (VIS) is a document designed by the Centers for Disease Control and Prevention (CDC) to provide information to a patient receiving a vaccine in the United States. The National Childhood Vaccine Injury Act requires that medical professionals provide a VIS to patients before receiving certain vaccinations.
In 2006, the CDC's Advisory Committee on Immunization Practices (ACIP) recommended a second dose of vaccine before school entry to ensure the maintenance of high levels of varicella immunity. [24] In 2006, the FDA approved Zostavax for the prevention of shingles. Zostavax is a more concentrated formulation of the Varivax vaccine, designed to ...
A zoster vaccine is a vaccine that reduces the incidence of herpes zoster (shingles), a disease caused by reactivation of the varicella zoster virus, which is also responsible for chickenpox. [8] Shingles provokes a painful rash with blisters, and can be followed by chronic pain ( postherpetic neuralgia ), as well as other complications.